![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 487/04 | (2006.01) |
A61K 31/519 | (2006.01) | ||
A61P 31/12 | (2006.01) |
(11) | Number of the document | 3412672 |
(13) | Kind of document | T |
(96) | European patent application number | 17747004.4 |
Date of filing the European patent application | 2017-02-04 | |
(97) | Date of publication of the European application | 2018-12-12 |
(45) | Date of publication and mention of the grant of the patent | 2020-07-15 |
(46) | Date of publication of the claims translation | 2020-11-10 |
(86) | Number | PCT/CN2017/072891 |
Date | 2017-02-04 |
(87) | Number | WO 2017/133684 |
Date | 2017-08-10 |
(30) | Number | Date | Country code |
201610082029 | 2016-02-05 | CN |
(72) |
DING, Zhaozhong, CN
SUN, Fei, CN
HU, Yinghu, CN
ZHOU, Yilong, CN
WANG, Zheng, CN
ZHAO, Rui, CN
YANG, Ling, CN
|
(73) |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.,
No. 369 Yuzhou South Road Haizhou District, Lianyungang, Jiangsu 222062,
CN
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | 2-Butoksi-7-(4-(pirolidin-1-ilmetil) benzil)-5H-pirolo[3,2-d]pirimidin-4-amino, kaip TLR7 agonisto, kristalinė forma, jos gamybos būdas ir panaudojimas |
CRYSTAL FORM A OF 2-BUTOXY-7-(4-(PYRROLIDIN-1-YLMETHYL) BENZYL)-5H-PYRROLO[3,2-D]PYRIMIDIN-4-AMINE AS TLR7 AGONIST, PREPARATION METHOD AND USE THEREOF |
Payment date | Validity (years) | Amount | |
2024-12-20 | 9 | 208.00 EUR |
2026-02-04 |